Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 May 15;62(10):470-7.
doi: 10.1007/BF01726909.

Primary aldosteronism due to adrenal carcinomas

Primary aldosteronism due to adrenal carcinomas

T Lüscher et al. Klin Wochenschr. .

Abstract

In the present study two patients with aldosterone-producing adrenal carcinomas are reported. The clinical features were characterized by hypertension and severe hypokalemia with muscular weakness, flaccid paralysis of arms and legs, diarrhea and polyuria. In both cases excessively high plasma aldosterone levels and suppressed plasma renin activity were found. In contrast to most other cases with aldosterone-secreting tumours plasma cortisol, urinary free cortisol excretion, 17-hydroxy- and 17-ketosteroids were in the normal range. There was no clinical evidence of oversecretion of sex hormones. After adrenalectomy blood pressure and serum potassium normalized and the clinical symptoms disappeared. Plasma aldosterone and urinary aldosterone secretion returned to normal, while plasma renin activity remained low. Three and a half and 6 months later primary aldosteronism and the associated clinical symptoms reappeared due to hormonally active metastases. After introducing the antitumour drug o,p'-DDD in patient 1 aldosterone secretion normalized and the clinical status of the patient markedly improved. However, 10 months after diagnosis the patient died due to a haemorrhage from a liver metastasis. In patient 2 tumour-invaded regional lymph nodes were surgically removed with only minor changes in the hormone pattern.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Endocrinol Metab. 1969 Oct;29(10):1349-55 - PubMed
    1. Am J Med. 1957 Sep;23(3):391-407 - PubMed
    1. Isr J Med Sci. 1977 Nov;13(11):1123-8 - PubMed
    1. J Clin Endocrinol Metab. 1972 Aug;35(2):225-9 - PubMed
    1. Nephron. 1980;26(4):189-94 - PubMed

LinkOut - more resources